









Markets
/
Stocks
/
nasdaq-hsic
/

Henry Schein Inc

HSIC

73.710USD

-0.540-0.73%

Close 03/26, 16:00（ET）Quotes delayed by 15 min

13.29BMarket Cap

22.37P/E TTM



Henry Schein Inc

73.710

-0.540-0.73%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Henry Schein Inc

Currency: USD Updated: 2026-03-25

Key Insights

Henry Schein Inc's fundamentals are relatively weak, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 44 out of 209 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 89.02.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Henry Schein Inc's Score

Industry at a Glance

Industry Ranking

44 / 209

Overall Ranking

130 / 4547

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Henry Schein Inc Highlights

StrengthsRisks

Henry Schein, Inc. is a solutions company for healthcare professionals. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.

Fairly Valued

The company’s latest PE is 22.54, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 129.67M shares, decreasing 13.15% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 447.00 shares of this stock.

Analyst Rating

Based on 16 analysts

Buy

Current Rating

89.016

Target Price

+19.55%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-25

The current financial score of Henry Schein Inc is 6.57, ranking 139 out of 209 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 3.44B, representing a year-over-year increase of 7.71%, while its net profit experienced a year-over-year increase of 7.45%.

Score

Industry at a Glance

Previous score

6.57

Change



Financials

3.84

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.77

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

6.67

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.53

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.04

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Henry Schein Inc's Company Valuation

Currency: USD Updated: 2026-03-25

The current valuation score of Henry Schein Inc is 6.95, ranking 137 out of 209 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 22.54, which is 39.80% below the recent high of 31.51 and 19.33% above the recent low of 18.18.

Score

Industry at a Glance

Previous score

6.95

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 44/209

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-25

The current earnings forecast score of Henry Schein Inc is 7.06, ranking 150 out of 209 in the Healthcare Equipment & Supplies industry. The average price target is 78.00, with a high of 90.00 and a low of 58.00.

Score

Industry at a Glance

Previous score

7.25

Change

-0.19

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 16 analysts

Buy

Current Rating

89.016

Target Price

+20.26%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

115

Total

Median

Average

Company name

Ratings

Analysts

Henry Schein Inc

HSIC

Medtronic PLC

MDT

Stryker Corp

SYK

Zimmer Biomet Holdings Inc

ZBH

Abbott Laboratories

ABT

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-25

The current price momentum score of Henry Schein Inc is 6.97, ranking 69 out of 209 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 80.93 and the support level at 69.41, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.95

Change

0.02

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.482

Sell

RSI(14)

40.480

Neutral

STOCH(KDJ)(9,3,3)

48.154

Neutral

ATR(14)

2.015

Low Volatility

CCI(14)

-27.878

Neutral

Williams %R

68.455

Sell

TRIX(12,20)

-0.322

Sell

StochRSI(14)

78.934

Sell

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

73.746

Sell

MA10

73.958

Sell

MA20

76.388

Sell

MA50

77.451

Sell

MA100

75.887

Sell

MA200

72.156

Buy

Institutional Confidence

Currency: USD Updated: 2026-03-25

The current institutional shareholding score of Henry Schein Inc is 10.00, ranking 1 out of 209 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 110.15%, representing a quarter-over-quarter decrease of 3.43%. The largest institutional shareholder is The Vanguard, holding a total of 11.56M shares, representing 10.08% of shares outstanding, with 14.07% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Kohlberg Kravis Roberts & Co. L.P.

15.65M

The Vanguard Group, Inc.

Star Investors

12.04M

+0.52%

Artisan Partners Limited Partnership

6.83M

+5.74%

BlackRock Institutional Trust Company, N.A.

5.27M

-9.77%

JP Morgan Asset Management

4.68M

-14.47%

State Street Investment Management (US)

4.48M

-14.23%

American Century Investment Management, Inc.

4.51M

-1.02%

Fidelity Management & Research Company LLC

3.05M

+8.86%

Dimensional Fund Advisors, L.P.

2.60M

+6.53%

Geode Capital Management, L.L.C.

2.82M

-10.24%

Risk Assessment

Currency: USD Updated: 2026-03-25

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Henry Schein Inc is 9.27, ranking 13 out of 209 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.89. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Henry Schein Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.